Solin LJ (2019) Management of ductal carcinoma in situ (DCIS) of the breast: present approaches and future directions. Curr Oncol Rep 21(4):33. https://doi.org/10.1007/s11912-019-0777-3

Article  PubMed  Google Scholar 

Mannu GS, Wang Z, Broggio J, Charman J, Cheung S, Kearins O et al (2020) Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988–2014: population based observational cohort study. BMJ 369:m1570. https://doi.org/10.1136/bmj.m1570

Article  PubMed  PubMed Central  Google Scholar 

Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P (2015) Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1(7):888–896. https://doi.org/10.1001/jamaoncol.2015.2510

Article  PubMed  Google Scholar 

Elshof LE, Schmidt MK, Rutgers EJT, van Leeuwen FE, Wesseling J, Schaapveld M (2018) Cause-specific mortality in a population-based cohort of 9799 women treated for ductal carcinoma in situ. Ann Surg 267(5):952–958. https://doi.org/10.1097/sla.0000000000002239

Article  PubMed  Google Scholar 

Dragun AE, Huang B, Tucker TC, Spanos WJ (2011) Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer. Cancer 117(12):2590–2598. https://doi.org/10.1002/cncr.25821

Article  PubMed  Google Scholar 

NKR: Overleving per jaren na diagnose. iknl.nl/nkr-cijfers (2021). Accessed 13/09/2023 2023.

Dinmohamed AG, Lemmens V, de Hingh I, Visser O (2020) Relative survival in early-stage cancers in the Netherlands: a population-based study. J Hematol Oncol 13(1):49. https://doi.org/10.1186/s13045-020-00888-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marcadis AR, Marti JL, Ehdaie B, Hakimi AA, Davies L, Morris LGT (2020) Characterizing relative and disease-specific survival in early-stage cancers. JAMA Intern Med 180(3):461–463. https://doi.org/10.1001/jamainternmed.2019.6120

Article  PubMed  Google Scholar 

Groen EJ, Hudecek J, Mulder L, van Seijen M, Almekinders MM, Alexov S et al (2020) Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study. Breast Cancer Res Treat 183(3):759–770. https://doi.org/10.1007/s10549-020-05816-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim M, Kim HJ, Chung YR, Kang E, Kim E-K, Kim SH et al (2018) Microinvasive carcinoma versus ductal carcinoma in situ: a comparison of clinicopathological features and clinical outcomes. J Breast Cancer 21(2):197–205

Article  PubMed  PubMed Central  Google Scholar 

Federatie Medisch Specialisten: Borstkanker - Aanbevelingen nacontrole. https://richtlijnendatabase.nl/richtlijn/borstkanker/nazorg_en_nacontrole/signalering_en_behandeling_van_gevolgen/aanbevelingen_nacontrole.html?query=controle#summary_literature (2021). Accessed 2021.

van der Sangen MJC, van de Poll-Franse LV, Roumen RMH, Rutten HJT, Coebergh JWW, Vreugdenhil G et al (2006) The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol (EJSO) 32(1):34–38. https://doi.org/10.1016/j.ejso.2005.10.005

Article  PubMed  Google Scholar 

Jager JJ, Volovics L, Schouten LJ, de Jong JMA, Hupperets PSGJ, von Meyenfeldt MF et al (1999) Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol 50(3):267–275. https://doi.org/10.1016/S0167-8140(98)00118-2

Article  CAS  PubMed  Google Scholar 

Luiten JD, Luiten EJT, van der Sangen MJC, Vreuls W, Duijm LEM, Tjan-Heijnen VCG et al (2021) Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands. Breast Cancer Res Treat 187(1):245–254. https://doi.org/10.1007/s10549-020-06055-w

Article  PubMed  PubMed Central  Google Scholar 

Kim C, Liang L, Wright FC, Hong NJL, Groot G, Helyer L et al (2018) Interventions are needed to support patient–provider decision-making for DCIS: a scoping review. Breast Cancer Res Treat 168(3):579–592. https://doi.org/10.1007/s10549-017-4613-x

Article  PubMed  Google Scholar 

King MT, Winters ZE, Olivotto IA, Spillane AJ, Chua BH, Saunders C et al (2017) Patient-reported outcomes in ductal carcinoma in situ: A systematic review. Eur J Cancer 71:95–108. https://doi.org/10.1016/j.ejca.2016.09.035

Article  PubMed  Google Scholar 

Mercieca-Bebber R, King MT, Boxer MM, Spillane A, Winters ZE, Butow PN et al (2017) What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions? Breast Cancer 24(5):720–729. https://doi.org/10.1007/s12282-017-0765-0

Article  PubMed  Google Scholar 

de Munck L, Kwast A, Reiding D, de Bock GH, Otter R, Willemse PHB et al (2013) Attending the breast screening programme after breast cancer treatment: a population-based study. Cancer Epidemiol 37(6):968–972. https://doi.org/10.1016/j.canep.2013.09.003

Article  PubMed  Google Scholar 

Ankersmid JW, Spronk PER, Zeillemaker AM, Siesling S (2022) Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty. Breast Cancer Res Treat 193(2):293–303. https://doi.org/10.1007/s10549-022-06549-9

Article  PubMed  PubMed Central  Google Scholar 

Grandjean I, Kwast AB, de Vries H, Klaase J, Schoevers WJ, Siesling S (2012) Evaluation of the adherence to follow-up care guidelines for women with breast cancer. Eur J Oncol Nurs 16(3):281–285. https://doi.org/10.1016/j.ejon.2011.07.004

Article  CAS  PubMed  Google Scholar 

Bleyer A, Welch HG (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367(21):1998–2005. https://doi.org/10.1056/NEJMoa1206809

Article  CAS  PubMed  Google Scholar 

Kerlikowske K (2010) Epidemiology of Ductal Carcinoma In Situ. JNCI Monographs 2010(41):139–141. https://doi.org/10.1093/jncimonographs/lgq027

Article  Google Scholar 

Benson JR, Wishart GC (2013) Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery. Lancet Oncol 14(9):e348–e357. https://doi.org/10.1016/S1470-2045(13)70135-9

Article  PubMed  Google Scholar 

Virnig BA, Tuttle TM, Shamliyan T, Kane RL (2010) Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102(3):170–178. https://doi.org/10.1093/jnci/djp482

Article  PubMed  Google Scholar 

Nederlandse Kankerregistratie: iknl.nl/nkr-cijfers (2023). Accessed 02–02–2023.

Luo C, Wang L, Zhang Y, Lu M, Lu B, Cai J et al (2022) Advances in breast cancer screening modalities and status of global screening programs. Chron Dis Translat Med 08(02):112–123. https://doi.org/10.1002/cdt3.21

Article  CAS  Google Scholar 

Draeger T, Voelkel V, Schreuder K, Veltman J, Dassen A, Strobbe L et al (2022) Adherence to the dutch breast cancer guidelines for surveillance in breast cancer survivors: real-world data from a pooled multicenter analysis. Oncologist 27(10):e766–e773. https://doi.org/10.1093/oncolo/oyac126

Article  PubMed  PubMed Central  Google Scholar 

Grunfeld E, Hodgson DC, Giudice MED, Moineddin R (2010) Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract 6(4):174–181. https://doi.org/10.1200/jop.200009

Article  PubMed  PubMed Central  Google Scholar 

Lu W, Jansen L, Schaapveld M, Baas PC, Wiggers T, De Bock GH (2011) Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer? BMC Cancer 11(1):279. https://doi.org/10.1186/1471-2407-11-279

Article  PubMed  PubMed Central  Google Scholar 

Borella F, Bertero L, Di Giovanni F, Witel G, Orlando G, Ricci AA et al (2023) COVID-19 and breast cancer: analysis of surgical management of a large referral center during the 2020–2021 pandemic period. Curr Oncol 30(5):4767–4778

Article  PubMed  PubMed Central  Google Scholar 

Ankersmid JW, Drossaert CHC, van Riet YEA, Strobbe LJA, Siesling S, Santeon VBCG (2022) Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance. J Cancer Survivorship. https://doi.org/10.1007/s11764-022-01178-z

Article